Phase 3 trial end-dates

flipflopper · Post by **flipflopper** » Fri Jan 23, 2009 6:41 pm

I do save a lot time and energy because of you Dignan. I also wanted to say thank you!

dignan · Post by **dignan** » Sat Jan 24, 2009 9:42 am

You're all welcome. I'm glad that I can use my obsessiveness for something useful.

CureOrBust · Post by **CureOrBust** » Sun Jan 25, 2009 6:58 am

now we just have to find something positive for your compulsions, and the OC will be sorted.

dignan · Post by **dignan** » Fri Jan 30, 2009 12:37 pm

Today's release of the data for the phase 2 RRMS dirucotide trial made me look into what is going on with the phase 2/3 SPMS trial that finished on January 22. I think I figured it out: participants are given the drug every 6 months for 24 months, so you get your last dose at month 24 (January 22, 2009 for the last patient I guess). I think they will then do a final evaluation of each patient 6 months after the last dose, so that means the data won't be put together until (I'm guessing) some time late in the third quarter of 2009. Maybe they'll have some headline data on the primary endpoint in August...maybe...

dignan · Post by **dignan** » Mon Sep 14, 2009 4:42 pm

I updated the list since they just completed enrollment in the second campath phase 3 trial last week.

dignan · Post by **dignan** » Thu Jan 21, 2010 4:13 pm

Thought I'd just update the first post in this thread since two BG00012 phase 3 trials have now completed enrollment, and cladribine and fingolimod have both been submitted for approval. Things are moving along, a lot more slowly than I'd like, but they're moving.